Lecturer of pathology, pathology department, faculty of medicine, Mansoura University, Egypt.
Assistant professor of pathology, Faculty of medicine, Mansoura University, Egypt.
J Immunoassay Immunochem. 2021 Nov 2;42(6):571-595. doi: 10.1080/15321819.2021.1911814. Epub 2021 Apr 25.
Squamous cell carcinoma (OSCC) is the commonest oral malignancy.The overall 5 year survival of OSCC has remained at 50%, largely unchanged for 40 years. CSCs are important within the development, invasion, drug resistance, and prediction of carcinomas treatment outcome. ALDH1 and CD44 are commonly used epithelial tumors cancer stem-like cells surface markers. Our study aimed to judge CD44 and ALDH1 immunohistochemical expressions in 44 cases of OSCC and relates the expression to patients' survival. High CD44 & ALDH1 expressions were significantly expressed in variable histologic grades of OSCCs, large sized carcinomas, presence lymph vascular invasion, presence of nodal and distant metastasis, advanced TNM clinical stage, recurrence and death during follow up period (P ≤ 0.05). Reduced DFS and three years overall survival were significantly recorded in cases with high CD44 expression, and high ALDH1 expression (p < 0.05). CD44 & ALDH1 expressions, histologic grade, tumor size were the independent predictors of DFS and three years OS. CD44 and ALDH1 expressions are valuable prognostic factors in OSCC and could be well considered predictors for patients' 3 years OS and DFS.
鳞状细胞癌(OSCC)是最常见的口腔恶性肿瘤。OSCC 的总体 5 年生存率在 40 年内保持在 50%不变。CSCs 在癌症的发展、侵袭、耐药性和治疗结果预测中很重要。ALDH1 和 CD44 是常用的上皮肿瘤癌症干细胞样细胞表面标志物。我们的研究旨在判断 44 例 OSCC 中 CD44 和 ALDH1 的免疫组织化学表达,并将其与患者的生存情况相关联。在 OSCC 的不同组织学分级、大肿瘤、存在淋巴血管侵犯、存在淋巴结和远处转移、晚期 TNM 临床分期、随访期间复发和死亡的病例中,CD44 和 ALDH1 的表达明显升高(P≤0.05)。CD44 高表达和 ALDH1 高表达的病例,DFS 和三年总生存率明显降低(p<0.05)。CD44 和 ALDH1 的表达、组织学分级、肿瘤大小是 DFS 和三年 OS 的独立预测因子。CD44 和 ALDH1 的表达是 OSCC 的有价值的预后因素,可作为患者 3 年 OS 和 DFS 的良好预测因子。